Skip to content
RegenCompliance
All articles
Specialty playbook

Addiction Treatment Marketing Compliance: LegitScript, Patient Brokering Laws, and the Specific Rules This Category Operates Under

If you market addiction treatment, recovery, or sober living services, you're in one of the most heavily regulated healthcare marketing categories. Here's the complete framework.

9 min readBy RegenCompliance Editorial, FDA/FTC compliance desk

Addiction treatment marketing is the most heavily regulated category in healthcare advertising. LegitScript certification is required for Google Ads. Patient brokering laws at federal (EKRA) and state levels criminalize certain marketing-based referral patterns. Telephone Consumer Protection Act (TCPA) rules apply to call-based marketing. State licensure and specific addiction-treatment advertising rules add layers. This post covers the framework for compliant marketing in this specialty.

LegitScript certification

Google Ads requires LegitScript certification for addiction treatment advertisers. LegitScript is a third-party certification program that verifies:

  • State licensure and accreditation.
  • Specific treatment practices.
  • Background of leadership and ownership.
  • Specific compliance with addiction-treatment marketing standards.

Certification takes weeks to months, requires documentation, and has annual renewal. Without it, Google Ads for addiction treatment is not available - which eliminates one of the primary patient acquisition channels for this category.

EKRA (Eliminating Kickbacks in Recovery Act)

EKRA is a federal criminal statute (18 USC §220) prohibiting certain payment arrangements in the addiction treatment industry. Key provisions:

  • Prohibits soliciting, receiving, paying, or offering remuneration for referring a patient to a recovery home, clinical treatment facility, or laboratory.
  • Applies even to private insurance payments (not just federal healthcare programs, unlike Anti-Kickback Statute).
  • Specific exceptions for salaried employees meeting certain criteria.
  • Criminal penalties: up to $200,000 fine and 10 years imprisonment per violation.

Marketing implications: referral fees, per-patient bounties, marketer compensation structures that vary with patient volume, and some influencer marketing arrangements can violate EKRA. This category’s marketing compensation structures need legal review.

State patient brokering laws

Several states have patient brokering laws specific to addiction treatment:

  • Florida.Patient Brokering Act is particularly strict, with criminal penalties. Florida’s statute was amended to increase penalties after widespread abuses in the state.
  • California. Specific rules against paid referrals in addiction treatment.
  • Other states. Varying rules; check state-specific statutes.

TCPA and call-based marketing

Call-based marketing (which is common in addiction treatment) faces TCPA restrictions:

  • Autodialed calls to mobile phones require prior express written consent.
  • Do Not Call Registry applies.
  • Statutory damages for violations ($500-$1,500 per call).
  • Class action exposure for patterns of violations.

Licensure and accreditation marketing

Marketing addiction treatment requires accurate representation of:

  • State licensure (varies by facility type, level of care, state).
  • Accreditation (Joint Commission, CARF, specific addiction- treatment accreditations).
  • Insurance acceptance.
  • Specific treatment modalities offered.

Misrepresentation of any of these has been a specific state AG enforcement focus, particularly in states with concentrated addiction-treatment industries.

Marketing patterns to avoid

Pattern 1: Guaranteed recovery claims

“Guaranteed to get you clean” or similar. Addiction recovery outcomes are highly variable; guarantee language both misrepresents outcomes and creates FTC exposure.

Pattern 2: Misleading “helpline” marketing

Marketing that presents for-profit facility intake as neutral “helpline” or “treatment locator” services has drawn specific FTC and state AG attention. The helpline-lookalike pattern is a specific enforcement category.

Pattern 3: False success rate claims

Specific success rate claims need substantiation. Most addiction-treatment providers cannot cite robust success rate evidence meeting FTC standards.

Pattern 4: Scare-based fentanyl and overdose marketing

Marketing that exploits fear of overdose or fentanyl crisis has drawn heightened scrutiny. Crisis-based conversion targeting vulnerable populations is a specific concern.

Pattern 5: Celebrity or influencer addiction-recovery content

Material connection disclosure is essential. Additional scrutiny on compensation structures that could implicate EKRA applies.

Compliant addiction treatment marketing

  1. LegitScript certification first. Without it, Google Ads is unavailable and many other channels reference it as a quality signal.
  2. EKRA-reviewed compensation structures.All marketing and referral compensation structures should be reviewed by healthcare regulatory counsel.
  3. Accurate licensure and accreditation representation. Specific state licenses held, specific accreditations, specific levels of care.
  4. Treatment approach framing. Describe the care approach, the team, the facility - not outcome promises.
  5. Recovery-honest framing. Recovery outcomes are variable; honesty about this is both compliant and more trusted by informed families.
  6. Dedicated compliance counsel. Healthcare regulatory attorney experienced with addiction treatment is essential for this category.

Frequently asked questions

How long does LegitScript certification take?

Typically 3-8 weeks for initial application review and certification. Complex cases can take longer. Annual renewal.

Can I use marketing agencies for addiction treatment?

Yes, but agency compensation structures need EKRA review. Per-lead or per-patient compensation arrangements can implicate EKRA depending on structure. Salaried or flat-fee arrangements are typically safer but need specific review.

Does EKRA apply to telehealth addiction services?

Yes. EKRA applies to any facility providing addiction treatment, including telehealth-only providers.

What about marketing medication-assisted treatment (MAT)?

MAT marketing combines addiction treatment rules with prescription drug advertising rules. Specific medications used (buprenorphine, methadone, naltrexone) have their own advertising considerations.

How do I handle patient testimonials?

With HIPAA authorization and particular care around typical-experience framing. Addiction recovery testimonials are particularly emotional and can create specific substantiation concerns.

What about sober living facility marketing?

Sober living is a specific subcategory with its own rules depending on state. Some states license and regulate sober living; others don’t. Marketing should accurately represent the service level and regulatory status.

Built for this exact problem

Scan your clinic's content before regulators do.

RegenCompliance checks every word of your marketing against live FDA and FTC enforcement data - and rewrites violations automatically. A 30-second scan can save a $50,000–$5M regulatory response.

Apply for betaTry the free demo

Related in the platform

hub

All specialty playbooks

Weekly compliance brief

One email a week. New enforcement actions, rule changes, and tactical fixes. No spam, unsubscribe anytime.

We only send one email per week. No marketing blasts.

Keep reading

FDA Warning Letters at a 25-Year High: What Every Healthcare Practice Needs to Know in 2026

More than 200 FDA warning letters hit healthcare practices in 2024 - the highest volume in a quarter century. Here is what is being flagged, why regenerative medicine and med spas are on the front line, and what a defensible marketing program looks like now.

Read article

How a Single Social Media Post Can Become a Multi-Million-Dollar FTC Settlement

Multi-million-dollar FTC settlements against stem cell and regenerative medicine clinics now routinely start with a single Instagram caption or Facebook testimonial. Here is how that chain actually works - and the four places clinics lose control of it.

Read article

Structure/Function Claims vs. Disease Claims: The One FDA Distinction That Determines Whether Your Marketing Is Legal

One line separates legal marketing from a warning letter: the difference between a structure/function claim and a disease claim. Most practice owners think they know where the line is. They are usually wrong by one or two key phrases.

Read article